Insider Trading March 19, 2026

Kepler Gust Sells $799,415 of REALLOYS Stock as Company Advances Rare-Earth Projects

Insider divestment coincides with a $50 million offering and plans for a metallization facility in Ohio

By Avery Klein ALOY
Kepler Gust Sells $799,415 of REALLOYS Stock as Company Advances Rare-Earth Projects
ALOY

Kepler Gust, a 10% owner of REALLOYS Inc. (ALOY), disposed of 62,000 shares on March 17, 2026, at $12.89 apiece, bringing the transaction value to $799,415. The company has recently completed a $50 million public offering and disclosed plans for a heavy rare earth metallization plant in Ohio, targeted to begin operations in early to mid-2027. REALLOYS also reported a new method for producing metallization-grade rare earth fluorides without hydrofluoric acid that meets industry standards.

Key Points

  • Kepler Gust sold 62,000 REALLOYS shares on March 17, 2026 at $12.89 per share, totaling $799,415; post-sale Gust owns 414,218 shares.
  • REALLOYS completed a $50 million public offering, issuing 2,702,702 shares at $18.50 each and granting a 30-day option for an additional 396,963 shares; Clear Street led the deal with Needham & Company as joint book-running manager.
  • The company plans a heavy rare earth metallization facility in Ohio, budgeted at roughly $40 million and expected to produce 30 tonnes of dysprosium and 15 tonnes of terbium per year starting early to mid-2027; it also demonstrated a fluorides production method that meets industry standards with 0.34% oxygen by weight.

Transaction details

Kepler Gust, identified as holding a 10 percent stake in REALLOYS Inc. (EXCHANGE: ALOY), sold 62,000 shares of the company's common stock on March 17, 2026. The sale price was $12.89 per share, producing proceeds of $799,415. After completing the sale, Gust retains direct ownership of 414,218 shares of REALLOYS.

The stock has since risen to $13.86, and the companyquity has recorded a 278% gain over the past year.


Recent capital markets activity

In a separate development, REALLOYS completed a public equity offering that aggregated $50 million in gross proceeds. The company issued 2,702,702 shares at $18.50 per share and granted the underwriters a 30-day option to purchase an additional 396,963 shares. Clear Street acted as the book-running manager for the deal, with Needham & Company serving as a joint book-running manager.


Operational expansion and technology update

REALLOYS announced plans to build a heavy rare earth metallization facility in Ohio, with operations expected to begin between early to mid-2027. The construction and commissioning of the facility are projected to cost approximately $40 million. Once operational, the plant is planned to produce 30 tonnes of dysprosium metal and 15 tonnes of terbium metal annually.

Separately, the company reported that it has demonstrated a process for producing metallization-grade rare earth fluorides that does not use hydrofluoric acid. The process reportedly achieves industry-standard material quality, with an oxygen content of 0.34% by weight.


Additional resources

InvestingPro subscribers can access comprehensive insider trading analysis and additional ProTips for ALOY.

Risks

  • The completed public offering increases the companyquity on the market and could result in dilution for existing shareholders; this impacts capital markets and materials-sector investors.
  • The Ohio metallization facility has an expected start window of early to mid-2027 and an approximate cost of $40 million, creating execution and timeline risk for the rare earths operations.
  • Details on commercial deployment and scale-up of the new hydrofluoric acid-free fluoride production method are limited in the disclosure, leaving uncertainty about near-term operational impact in the rare earth metals sector.

More from Insider Trading

Alignment Healthcare CHRO Disposes $425k in Shares Across Two Transactions Mar 19, 2026 CytomX SVP Sells Shares to Cover RSU Taxes as Company Advances Clinical and Financing Plans Mar 19, 2026 Silver Lake Sells $36.7M in Dell Shares as Company Reports Strong AI Server Performance Mar 19, 2026 CytomX CFO Sells $124,111 in Stock as Company Advances Clinical Programs and Launches Large Offering Mar 19, 2026 Silver Lake Entities Liquidate $36.6M in Dell Class C Stock Amid Ongoing AI Momentum Mar 19, 2026